CCR7 and acute lymphoblastic leukemia: Indeed, pioneering pre-clinical studies using CCR7 function-blocking single-chain antibodies demonstrated that these pre-clinical biologicals blocked T-ALL cell transmigration across a human brain endothelial cell monolayer, and Ca2+ mobilization in vitro [308].